Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07138040 · ClinicalTrials.gov registry record · NA

Re-Engaging AYA Survivors in Cancer-Related Healthcare

A NA study of Cancer, sponsored by Children's Hospital of Philadelphia.

Recruiting
Registry status
NA
Development phase
530
Enrollment target
3
Study locations

NCT07138040 is a NA study of Cancer that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 530 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07138040, a NA study of Cancer, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.

RECRUITING
Registry status
NA
Development phase
530 participants
Enrollment target
3
Study locations

Study Summary

The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood cancer to promote re-engagement in cancer-related long-term follow-up care (LTFU). The main aims are: * To test the efficacy of adaptive interventions (AIs) that begin with low touch intervention (LTI) as compared to written information (WI) on attending an appointment, and self-reported self-management among AYA. * To identify the most efficacious second-stage strategy for those who initially schedule/attend an appointment (maintenance vs. step-up) and for those who do not (step-up vs. step-up maximum). * To assess multilevel factors contributing to the effects of re-engaging AYA and how best to integrate AIs into practice. Throughout the duration of the study, participants will complete four surveys, receive a series of interventions, and may be asked to participate in an interview (post-intervention).

Conditions Studied

Interventions

  • BEHAVIORAL Stage 1 Written Information
  • BEHAVIORAL Stage 1 Low Touch Intervention
  • BEHAVIORAL Stage 2 Written Information
  • BEHAVIORAL Stage 2 Low Touch Intervention
  • BEHAVIORAL Stage 2 High Touch Intervention

Study Locations (3)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia
  • Penn Medicine - Philadelphia

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 530 participants
Start Date 2025-08-01
Est. Completion 2028-04-30
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT07138040

The ClinicalTrials.gov registry entry for NCT07138040 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 530 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Stage 1 Written Information is the first listed.

NCT07138040 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Ohio.

Frequently Asked Questions

What is clinical trial NCT07138040 about?

NCT07138040 is a clinical study titled "Re-Engaging AYA Survivors in Cancer-Related Healthcare". The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood cancer to promote re-engagement in cancer-related long-term follow-up care (LTFU). The main aims are: *...

What is the current status of trial NCT07138040?

This trial is currently recruiting. It is a NA study. The enrollment target is 530 participants. The study started on 2025-08-01. Estimated completion is 2028-04-30.

What conditions does trial NCT07138040 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT07138040?

The interventions under investigation include: Stage 1 Written Information (BEHAVIORAL), Stage 1 Low Touch Intervention (BEHAVIORAL), Stage 2 Written Information (BEHAVIORAL), Stage 2 Low Touch Intervention (BEHAVIORAL), Stage 2 High Touch Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07138040?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07138040 being conducted?

This trial has 3 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.